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A B S T R A C T
Objective
The ketogenic diet is used as a therapeutic alternative for the treatment of epilepsy in patients with refractory
epilepsy. It simulates biochemical changes typical of fasting. The present study verified the nutritional impact
of the ketogenic diet on children with refractory epilepsy.
Methods
Nutritional status data (dietary, biochemical and anthropometric measurements), seizure frequency, and adverse
events were collected from the medical records and during outpatient clinic visits of children over a period of
36 months.
Results
Of the 29 children who initiated the ketogenic diet, 75.8% presented fewer seizures after one month of
treatment. After six months, 48.3% of the patients had at least a 90.0% decrease in seizure frequency, and
50.0% of these patients presented total seizure remission. At 12 months, eight patients continued to show
positive results, and seven of these children remained on the ketogenic diet for 24 months. There was an
improvement of the nutritional status at 24 months, especially in terms of weight, which culminated with the
recovery of proper weight-for-height. There were no significant changes in biochemical indices (total cholesterol
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and components, triglycerides, albumin, total protein, creatinine, glycemia, serum aspartate transaminase and
serum alanine transaminase). Serum cholesterol levels increased significantly in the first month, fell in the
following six months, and remained within the normal limits thereafter.
Conclusion
In conclusion, patients on the classic ketogenic diet for at least 24 months gained weight. Moreover,
approximately one third of the patients achieved significant reduction in seizure frequency, and some patients
achieved total remission.
Indexing terms: Epilepsy. Ketogenic diet. Nutritional status.
R E S U M O
Objetivo
A dieta cetogênica é empregada como uma terapia alternativa para o tratamento da epilepsia em pacientes
com epilepsia refratária e simula as alterações bioquímicas de jejum. Neste trabalho, verificou-se o impacto
nutricional da dieta cetogênica em crianças com epilepsia refratária.
Métodos
Os dados sobre o estado nutricional (bioquímica, alimentar e medidas antropométricas), a frequência de crises
e os eventos adversos de crianças acompanhadas durante 36 meses foram coletados de prontuários médicos e
visitas ambulatoriais.
Resultados
Vinte e nove crianças iniciaram o tratamento; após um mês, 75,8% apresentaram redução das crises. Em seis
meses, 48,3% dos pacientes tiveram pelo menos 90,0% de redução na frequência de crises, e, desses, 50,0%
obtiveram o controle completo das crises. Aos doze meses, oito pacientes continuaram a apresentar resultados
positivos, e, desses, sete permaneceram em dieta cetogênica durante 24 meses. Observou-se melhora do esta-
do nutricional aos 24 meses de tratamento, especialmente em termos de peso, o que indica a recuperação da
condição peso para altura. Não houve mudanças significativas nos índices bioquímicos analisados (colesterol
total e de componentes, triglicerídeos, albumina, proteína total, creatinina, glicemia, transaminase glutâmico
oxala-cética sérica e transaminase glutâmico pirúvico sérica). Os níveis de colesterol aumentaram signi-
ficativamente no primeiro mês, mas diminuíram nos seis meses seguintes e, posteriormente, se mantiveram
dentro dos valo-res de referência.
Conclusão
Os pacientes em uso da dieta cetogênica clássica por pelo menos 24 meses apresentaram melhora de peso e
cerca de um terço dos pacientes conseguiu uma redução significativa da frequência de crises, com alguns
pacientes completamente livres delas.
Termos de indexação: Epilepsia. Dieta cetogênica. Estado nutricional.
I N T R O D U C T I O N
The Ketogenic Diet (KD), the so-called
modified Atkins diet, and the low-glycemic index
treatment have all emerged over the past decade
as important therapeutic options for children with
refractory epilepsy1,2. Whereas only a decade ago
the KD was seen as a last resort, its global use
now is more common1.
The KD simulates biochemical changes
associated with fasting and is used especially in
children with refractory epileptic seizures3. It could
potentially be used in epileptic syndromes and
specific conditions, providing specific benefits in
conditions such as glucose transporter protein I
(GLUT I) deficiency, pyruvate dehydrogenase
deficiency (PDHD), myoclonic-astatic epilepsy
(Doose syndrome), tuberous sclerosis complex,
Rett syndrome, and severe myoclonic epilepsy in
infancy (Dravet syndrome)4,5. This diet can also
be used by patients that do not tolerate the
adverse side effects of anticonvulsant drugs3.
Fasting ketosis is mimicked by using fats
to provide 90% of the dietary energy and the
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remainder 10% coming from carbohydrates and
proteins6,7, to a limit of 75% of the recommended
daily energy intake8. The term ‘ketogenic ratio’
has been used to describe the ratio of ketone-
producing foods (for instance, dietary fat) to foods
that reduce ketone production (for instance,
carbohydrate and protein), and the most
frequently used proportion is 4:18-10. To provide
the general principles of nutrition and meet the
energy, protein, mineral and vitamin requirements,
patients on the KD should take multivitamin and
mineral supplements on a daily basis to improve
and maintain their physiological wellbeing11.
The progress of refractory epilepsy in
children submitted to multidrug treatment usually
leads to neurological deterioration12. Moreover,
frequent seizures and post-seizure periods reduce
the time a child remains awake, which may lead
to low total energy intake. Side effects of
antiepileptic drugs usually occur, and they increase
with polytherapy. Among the undesirable effects
are low appetite, difficulty chewing and swallowing,
vomiting, malabsorption of nutrients like iron and
zinc, and changes in energy balance. Therefore,
repeated seizures and drug treatment may impair
growth and cause nutritional problems, which are
common in these children13-15.
Bertoli et al.16 reported that 40% of the
children with refractory epilepsy have a low
weight-for-age Z-score, and 24% have chronic
undernourishment, that is, Low Weight-for-Height
(W/H) and Height-for-Age (H/A) Z-scores. In this
same study, the mean daily energy intake was
below the requirement, and inadequate
macronutrient intake was evident. This suggested
that the diet was high in proteins and lipids, and
in low carbohydrates and fibers.
The ketogenic diet has been used for the
treatment of refractory epilepsy for many years
with good clinical results17. Its effectiveness has
been reported in many studies, which have
demonstrated significant reduction in seizure
frequency18,19. The aim of this study was to
evaluate the effect of a classic KD on nutritional
status and seizure frequency in children with
refractory epilepsy before, during, and after a six-
month period of dietary treatment.
M E T H O D S
The present study consisted of a retrospective
and a prospective stage. The 29 participants had
drug-resistant epilepsy with more than one seizure
daily and were thus placed on a KD. The KD was
introduced during hospital stay, after a 24-hour
fast. After hospital discharge, the subjects were
followed in outpatient clinics. This study was
approved by the local Research Ethics Committee
under protocol number 12267/2005, and an
informed consent was signed by all the participants’
legal guardians.
The study demographic data included sex,
age at epilepsy onset, age at KD introduction,
epileptic syndrome diagnosis according to the
classification of the International League Against
Epilepsy (ILAE)20, Magnetic Resonance Imaging
(MRI) and electroencephalogram (EEG) findings,
seizure frequency before and after KD introduction,
and clinical complications. The antiepileptic drug
was not changed for at least six months after KD
initiation, and then it was progressively reduced
in seizure-free patients.
The use of vitamin and mineral supplements
(Table 1) was initiated after KD introduction;
evaluation of their necessity and efficacy was done
by laboratory tests. The KD was immediately
halted when there was no improvement within 2
months. KD interruption was abrupt, without a
progressive reduction in the amount and ratio of
fat intake.
Anthropometric assessment included
weight, height, W/H and H/A according to the
criteria established by Waterlow21. This method
allowed the calculation of W/H and H/A adequacy
with respect to the 50% weight and height
percentiles of the National Center for Health
Statistics (NCHS) standards22. Laboratory tests
568 | LD MARTINS et al.
Rev. Nutr., Campinas, 25(5):565-573, set./out., 2012Revista de Nutrição
were also done to investigate possible nutritional
deficiencies and diseases associated with the KD.
The levels of albumin, total proteins, triglycerides,
total cholesterol, Low Density Lipoprotein-
cholesterol (LDL-c), High Density Lipoprotein-
cholesterol (HDL-c), vitamin A, beta carotene, iron,
calcium, phosphorus, potassium, sodium, zinc,
magnesium, glycemia, urea, creatinine, Aspartate
Transaminase (AST) and Alanine Transaminase
(ALT) were measured and complete blood count
done. Patients were examined at 1, 6, 12 and 24
months after KD introduction and 12 months after
KD discontinuation.
The efficacy of the KD was assessed by
means of seizure activity on the basis of seizure
frequency recorded by the participants’ parents.
R E S U L T S
Demographic data
Thirteen (44.8%) of the 29 patients were
boys. The mean age at epilepsy onset was 6.5
months (ranging from 0 to 30 months), and the
mean age at the beginning of the KD diet was
6.1, Standard Deviation (SD)=3.4 years (ranging
from 1 to 15 years). Subjects were kept on the
KD for a mean of 11 (SD=11) months. Seizure
types included generalized symptomatic (62%),
focal symptomatic (24.1%), generalized
cryptogenic (10.3%), and focal cryptogenic
(3.6%) events. Fifty percent of the patients with
generalized symptomatic epilepsy had Lennox-
Gastaut syndrome (9/18 patients). MRI findings
were: cortical developmental abnormalities
(34.5%), diffuse cortical atrophy (34.5%), gliosis
(13.7%) and congenital infection (3.6%). MRI was
normal for four patients. All patients had
developmental delays, and delay was severe in
75.9% and moderate in 24.1% of the children.
Seizure frequency ranged from three to numerous
seizures daily.
All patients were submitted to interictal
electroencephalogram before the introduction of
the KD, revealing abnormal baseline activity.
Almost all of them had moderate disorganization
(27/29). Multifocal interictal epileptiform discharges
were observed in high, moderate, and rare
incidences in 17, 10, and 2 patients, respectively. All
patients with Lennox-Gastaut syndrome had a
high incidence of spikes.
Nutritional assessment and side effects
During hospital stay and before KD
initiation, 34.5% of the participants had normal
weight and 65.5% were undernourished; 51.7%
had acute and 10.3% had chronic undernutrition,
and 3.5% had had undernutrition in the past.
Of the seven participants that stayed on
the KD until the end of the study, 14.3% had
Table 1. Composition of the nutritional supplement taken by
patients during the study.
Vitamin A (UI)
Vitamin E (UI)
Vitamin C (mg)
Pantothenic acid (mg)
Folic acid (mcg)
Biotin (mcg)
Calcium (mg)
Vitamin B12 (mcg)
Vitamin B6 (mg)
Chlorine (mg)
Copper (mg)
Cholecalciferol (UI)
Chrome (mcg)
Tin (mcg)
Iron (mg)
Vitamin K1 (mcg)
Phosphorus (mg)
Iodine (mcg)
Magnesium (mg)
Manganese (mg)
Molybdenum (mcg)
Thiamine (mg)
Nicotinamide (mg)
Nickel (mcg)
Potassium (mg)
Riboflavin (mg)
Selenium (mcg)
Silicon (mcg)
Vanadium (mcg)
Zinc (mg)
Nutrients
5000,0
0030,0
0060,0
0010,0
0400,0
0030,0
0162,0
0006,0
0002,0
0036,3
0002,0
0400,0
0025,0
0010,0
0018,0
0025,0
0125,0
0150,0
0100,0
0002,5
0025,0
0001,5
0020,0
0005,0
0040,0
0001,7
0025,0
0010,0
0010,0
0015,0
Amount
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normal weight before starting the diet. The
remainder 85.7% were undernourished, all of
which had acute undernutrition. At the end of
the study, patients presented with improved
nutritional status, especially in terms of weight,
recovering proper W/H. The final results were as
follows: 28.6% of the subjects had normal weight,
71.4% were undernourished, 42.8% had had
undernutrition in the past, that is, were presently
stunted, and only 28.6% presented chronic
undernutrition (Figure 1).
Analysis of biochemical parameters
evidenced a significant rise in serum cholesterol
levels in the first month, followed by a reduction
at six months, and maintenance of constant values
thereafter, with no significant differences six
months after KD was discontinued (Figure 2).
There was no significant difference in the
mean triglyceride levels during the KD, but 6.9%
(2/29) of the participants had hypertriglyceridemia
but the levels went back to normal at the end of
the diet. Blood glucose of only one patient (1/29)
did not stay within the reference values.
There were no changes in serum albumin
in the first 6 months of the study. Only one patient
(1/29) experienced severe hypoalbuminemia at 11
months, so the treatment was discontinued. There
were no significant differences in serum albumin
concentrations or in total serum protein
concentrations of the other subjects throughout
the study period,
Figure 1. Weight over time in epileptic patients on a classic
ketogenic diet.
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Figure 2. Serum HDL-c, LDL-c and total cholesterol levels over
time in epileptic patients treated with the classic
ketogenic diet.
Notas: HDL-c: High Density Lipoprotein-cholesterol; LDL-c: Low Density
Lipoprotein-cholesterol; UL: Upper Limit; LL: Lower Limit.
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Six individuals (20.7%) had high AST and
ALT levels before the beginning of the KD. The
liver function of these patients became normal
after some time on the diet, and serum AST
and ALT levels were within the normal ranges
(Figure 3).
The mean vitamin A, iron, calcium,
phosphorus, potassium, sodium, zinc, magnesium,
blood glucose, urea, and creatinine levels did not
vary significantly throughout the study.
In the beginning of the KD, two patients
discontinued treatment: one due to complications
in the ventriculoperitoneal shunt (VP shunt) and
another because of persistent vomiting. The
commonest side effects after the initial stage of
the diet were gastrointestinal symptoms (9/29): 6
patients had nausea and vomiting, 2 presented
with constipation or diarrhea, and 1 experienced
difficulty taking in fluids and accepting the diet.
Two children had dehydration and severe
metabolic acidosis, which led to hospitalization.
They were intravenously hydrated with glucose-
free solutions or lactate. In the long-term, the
patients presented with other complications such
as hypoalbuminemia, hypoproteinemia, water-
electrolyte imbalance, kidney stones, hypercholes-
terolemia, low fluid intake and refusal of the diet.
Seizure frequency over time
Only 7 of the initial 29 patients remained
on the KD until the end of the study (Table 2).
Within the first months of the diet, seven subjects
dropped out of the study because of
unresponsiveness to treatment; the seizure
frequency of the remainder participants dropped
so they stayed on the diet, and three children
became seizure-free. At six months, five more
children were excluded from the study for
unresponsiveness; three were excluded because
of adverse events; and 14 children had at least a
Figure 3. Serum Aspartate Transaminase and Alanine
Transaminase levels over time in epileptic patients
treated with the classic ketogenic diet.
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Table 2. Time course of the number of patients on the ketogenic diet in May, 2007.
>50% reduction of seizures
Seizure-free
Inefficient
Adverse events
Discontinued
Seizure frequency
19
3
7
-
-
1 months (n=29)
7
7
5
3
-
6 months (n=22)
4
4
2
3
1
12 months (n=14)
2
5
-
1
-
24 months (n=8)
2
5
-
-
-
After KD (n=7)
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90% reduction in seizure frequency. Of the eight
participants that were still on the diet at 12
months, four were completely seizure-free and
four had a 90% reduction in seizure frequency.
At 24 months, one patient presented with kidney
stones and discontinued the treatment. At the
end of 24 months, all patients discontinued the
KD and were followed for another 12 months.
During this period, five patients remained seizure-
free and two patients had an increase in seizure
frequency.
The dosages of the antiepileptic drug of
patients with reduced seizure frequency and
seizure-free were reduced. At the end of the study,
two patients were medication-free and remained
with the same seizure frequency or absence as
the previous year, when KD was discontinued. Two
participants continued taking the same dosage,
and the dosages of three were reduced.
D I S C U S S I O N
The retrospective assessment of 29
patients and the follow-up of seven children with
refractory epilepsy placed on the classic KD
resulted in good seizure control. Recovery of the
nutritional status is essential for the proper growth
and development of the patients, and the effect
of the KD in this process is not clear. There are
few studies on the risks posed by the KD, mainly
with respect to its nutritional impact23. Studies
have reported significant weight and height gains
after 4 to 6 months of a KD24. Another similar
study assessed the growth of children placed on
a KD for one year and found that height and
weight remained within the normal range; at the
end of the study period, growth was similar to
that of normal children. In contrast, Williams et al.25
reported that children on a KD followed for 1.2
years presented suboptimal growth, emphasizing
the need for the nutritional follow-up of patients
treated with this diet. Similar results have been
observed by other authors. Tumas et al.26
demonstrated a decrease in mean weight-for-age
and H/A in 20 patients using a KD followed for
12 months, whereas Peterson et al.27 detected
significant reduction of H/A and W/A Z-scores and
percentiles in children using a KD for 12 months.
In the present study, there was a high
percentage of previously undernourished patients,
but after the 24-month study period or longer,
these patients reached a normal weight. This
result confirms the findings of Liu et al.24 and is
probably related to adequate daily energy intake.
However, considering the long-term effect of the
KD on growth rates, the height of the present
sample did not recover after a 24-month follow-
up. Liu et al.24 observed height recovery after a
short follow-up period, but other studies involving
the use of KD and longer follow-ups did not
corroborate their findings, suggesting that
patients on long-term use of KD should be closely
monitored26,27.
Some studies have evidenced a slight rise
in total cholesterol and triglyceride levels in
children on the KD because of refractory epilepsy28.
Hosain et al.29 demonstrated that total cholesterol
and triglycerides significantly increased in 14.5%
and 36.2% of the patients on a KD, respectively;
however, cholesterol concentrations higher than
230mg/dL and serum triglyceride levels higher
than 190mg/dL were considered high in their
work. Liu et al.24 have compared the classic KD
with the KD based on medium-chain triglycerides
(MCT) and showed that patients following the
classic KD had increased total cholesterol and LDL
levels, whereas those that received MCT had
significant reduction in total cholesterol and LDL,
with increased HDL.
Laboratory tests revealed similar results for
serum albumin, blood glucose and liver enzymes
when compared with baseline findings during KD
use. These data agree with those published by
other authors14,30.
The efficacy of the KD for the treatment
of epilepsy is currently widely accepted. Kang et
al.31 have described that after a 12-month period
on the classic KD, 23 to 44% of the patients had
a 50% decrease in seizure activity, and 7% to
22% of these were completely seizure-free.
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In a study with patients following a KD,
Hartman & Vining32 investigated how age, sex,
epileptic syndrome, and electrographic pattern
affected KD efficacy, but these authors did not
find anything significant. Hence, these authors
suggested that KD should be considered an
alternative treatment for any patient with
drug-resistant epilepsy.
C O N C L U S I O N
Despite the small size of our sample, our
results corroborate the use of KD as an important
and effective alternative for the treatment of
patients with refractory epilepsy. However, a more
detailed nutritional follow-up is essential to ensure
appropriate nutrition to the growth and
development of these patients.
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